Vascular Endothelial Growth Factor Inhibitor market grows 4.0% CAGR as biosimilars and personalized medicine expand ...

TIGIT inhibitors present a strong market opportunity, with numerous global players advancing in immuno-oncology. Key opportunities lie in developing and commercializing emerging therapies, especially ...

DUBLIN--(BUSINESS WIRE)--The "CDK4/6 Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. This report ...

The CTLA-4 inhibitors market offers promising opportunities in cancer immunotherapy, with over 40 companies developing 50+ drugs globally. Key opportunities include leveraging synergistic combinations ...

DelveInsight's BCL-2 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

Monday, Relay Therapeutics Inc. (NASDAQ:RLAY) shared interim data for RLY-2608 from the ReDiscover study of RLY-2608 alone, in combination with fulvestrant, and in combination with fulvestrant and ...

Corrosion inhibitors market to grow from $9.15 B in 2024 to $13.03 B by 2033, registering a 4.01% CAGR amid rising ...

The JAK inhibitors market offers significant opportunities in treating autoimmune and rheumatic diseases through diverse product development by over 40 companies and 45 drugs. Key areas include ...